Thiabendazole (TBZ) nephrotoxicity and recovery in ICR adult mice

Y Tada1, T Fujitani, M Yoneyama

  • 1Department of Toxicology, Tokyo Metropolitan Research Laboratory of Public Health, Japan.

Toxicology
|November 1, 1994
PubMed

Insights

Thiabendazole (TBZ) causes dose-dependent kidney damage, specifically proximal tubular necrosis, in mice. Renal injury peaks at 2-3 days post-dose, followed by significant tubular regeneration.

Area of Science:

  • Toxicology
  • Nephrology
  • Pharmacology

Background:

  • Thiabendazole (TBZ) is an anthelmintic drug.
  • Understanding TBZ's renal effects is crucial for safe usage.
  • Previous studies have not fully detailed TBZ-induced nephrotoxicity and recovery.

Purpose of the Study:

  • To investigate the nephrotoxicity of thiabendazole (TBZ) in ICR adult mice.
  • To characterize the time course of kidney injury and recovery following TBZ administration.
  • To correlate pathological kidney changes with clinical and biochemical markers.

Main Methods:

  • Adult ICR mice received single oral doses of TBZ (500-2000 mg/kg).
  • Kidney tissues were examined using light and electron microscopy at various time points (1-10 days).
  • Serum urea nitrogen, urinalysis, and kidney weight were measured.

Main Results:

  • TBZ caused dose-dependent proximal tubular necrosis and increased serum urea nitrogen.
  • Renal injury was most severe 2-3 days after high-dose TBZ administration.
  • Tubular regeneration began by day 3 and was substantial by day 5; mitochondrial swelling observed.

Conclusions:

  • TBZ induces significant, but reversible, nephrotoxicity in mice.
  • The severity of TBZ-induced renal injury is dose-dependent.
  • Kidney function and structure recover within 5-10 days post-exposure.

Related Concept Videos